ANCA-associated vasculitis in childhood: recent advances
Open Access
- 5 May 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Italian Journal of Pediatrics
- Vol. 43 (1), 46
- https://doi.org/10.1186/s13052-017-0364-x
Abstract
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides are rare systemic diseases that usually occur in adulthood. They comprise granulomatosis with polyangiitis (GPA, Wegener’s), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss syndrome). Their clinical presentation is often heterogeneous, with frequent involvement of the respiratory tract, the kidney, the skin and the joints. ANCA-associated vasculitis is rare in childhood but North-American and European cohort studies performed during the last decade have clarified their phenotype, patterns of renal involvement and their prognostic implications, and outcome. Herein, we review the main clinical and therapeutic aspects of childhood-onset ANCA-associated vasculitis, and provide preliminary data on demographic characteristics and organ manifestations of an Italian multicentre cohort.Keywords
This publication has 60 references indexed in Scilit:
- Rituximab versus Azathioprine for Maintenance in ANCA-Associated VasculitisThe New England Journal of Medicine, 2014
- The New Histopathologic Classification of ANCA-Associated GN and Its Association with Renal Outcomes in ChildhoodClinical Journal of the American Society of Nephrology, 2014
- 2012 Revised International Chapel Hill Consensus Conference Nomenclature of VasculitidesArthritis & Rheumatism, 2012
- Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-upAnnals Of The Rheumatic Diseases, 2011
- Long- term outcome of paediatric patients with ANCA vasculitisPediatric Rheumatology, 2011
- EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteriaAnnals Of The Rheumatic Diseases, 2010
- Clinical features and outcome of pediatric Wegener's granulomatosisArthritis Care & Research, 2007
- Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitidesArthritis & Rheumatism, 1997
- Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.1994
- Systemic Vasculitis with Asthma and EosinophiliaMedicine, 1984